Top

Published in:

Open Access 01-10-2014 | Original Article

The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: a review of the current evidence

Authors: Magdalena Urbańska, Hania Szajewska

Published in: European Journal of Pediatrics | Issue 10/2014

Abstract

We aimed to systematically evaluate evidence on the effectiveness of Lactobacillus reuteri DSM 17938 (L. reuteri) for treating and preventing diseases in infants and children. MEDLINE and the Cochrane Library were searched in December 2013, with no language restrictions, for relevant randomized controlled trials (RCTs) and meta-analyses. The search was updated in April 2014. One systematic review and 14 RCTs met the inclusion criteria. The use of L. reuteri may be considered in the management of acute gastroenteritis as an adjunct to rehydration. There is some evidence that L. reuteri is effective in reducing the incidence of diarrhea in children attending day care centers. There is no evidence of effectiveness of L. reuteri in preventing nosocomial diarrhea in children. The administration of L. reuteri is likely to reduce crying time in infants with infantile colic in exclusively or predominantly exclusively breast-fed infants, but not in formula-fed infants. More studies are needed. Preliminary data suggest that L. reuteri may be effective in the prevention of some functional gastrointestinal disorders, such as colic and regurgitation. This innovative approach needs further evaluation by an independent research team. Preliminary evidence provides a rationale for further assessing the efficacy of L. reuteri for treating functional constipation or functional abdominal pain. However, it is too soon to recommend the routine use of L. reuteri for these conditions. There are no safety concerns with regard to the use of L. reuteri in nonimmunocompromised subjects. There are also data to support the safety of using L. reuteri in preterm infants. Conclusion: Our results precisely define current evidence on the effects of the administration of L. reuteri DSM 17938 to the pediatric population.

Agustina R, Bovee-Oudenhoven IM, Lukito W, Fahmida U, van de Rest O, Zimmermann MB, Firmansyah A, Wulanti R, Albers R, van den Heuvel EG, Kok FJ (2013) Probiotics Lactobacillus reuteri DSM 17938 and Lactobacillus casei CRL 431 modestly increase growth, but not iron and zinc status, among Indonesian children aged 1–6 years. J Nutr 143(7):1184–1193PubMedCrossRef

Axelson LT, Chung TC, Dobrogosz WJ, Lindgren SE (1989) Production of a broad spectrum antimicrobial substance by Lactobacillus reuteri. Microb Ecol Health Dis 2:131–136CrossRef

Chung TC, Axelsson L, Lindgren SE, Dobrogosz WJ (1989) In vitro studies on reuterin synthesis by Lactobacillus reuteri. Microb Ecol Health Dis 2:137–144CrossRef

Coccorullo P, Strisciuglio C, Martinelli M, Miele E, Greco L, Staiano A (2010) Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo- controlled study. J Pediatr 157(4):598–602PubMedCrossRef

Dinleyici EC, PROBAGE Study Group, Vandenplas Y (2014) Lactobacillus reuteri DSM 17938 effectively reduces the duration of acute diarrhoea in hospitalised children. Acta Paediatr. doi:10.1111/apa.12617 PubMed

Egervärn M, Lindmark H, Olsson J, Roos S (2010) Transferability of a tetracycline resistance gene from probiotic Lactobacillus reuteri to bacteria in the gastrointestinal tract of humans. Antonie Van Leeuwenhoek 97(2):189–200PubMedCrossRef

FDA (2012) Available via DIALOG: http://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm300525.htm. Accessed 2 Mar 2014

Food and Agriculture Organization of the United Nations (FAO) (2001) Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Available via DIALOG: http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf. Accessed 25 Feb 2014

Francavilla R, Lionetti E, Castellaneta S, Ciruzzi F, Indrio F, Masciale A, Fontana C, La Rosa MM, Cavallo L, Francavilla A (2012) Randomised clinical trial: Lactobacillus reuteri DSM 17938 vs. placebo in children with acute diarrhoea–a double-blind study. Aliment Pharmacol Ther 36(4):363–369PubMedCrossRef

10.

Garofoli F, Civardi E, Indrio F, Mazzucchelli I, Angelini M, Tinelli C, Stronati M (2014) The early administration of Lactobacillus reuteri DSM 17938 controls regurgitation episodes in full-term breastfed infants. Int J Food Sci Nutr. doi:10.3109/09637486.2014.898251 PubMed

11.

Grześkowiak Ł, Isolauri E, Salminen S, Gueimonde M (2011) Manufacturing process influences properties of probiotic bacteria. Br J Nutr 105(6):887–894PubMedCrossRef

12.

Gutierrez- Castrellon P, Lopez- Velazquez G, Diaz- Garcia L, Jimenez- Gutierrez C, Mancilla- Ramirez J, Estevez- Jimenez J, Parra M (2014) Diarrhea in preschool children and Lactobacillus reuteri: a randomized controlled trial. Pediatrics 133:e904PubMedCrossRef

13.

Indrio F, Di Mauro A, Riezzo G, Civardi E, Intini C, Corvaglia L, Ballardini E, Bisceglia M, Cinquetti M, Brazzoduro E, Del Vecchio A, Tafuri S, Francavilla R (2013) Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation: a randomized clinical trial. JAMA Pediatr 168(3):228–233CrossRef

14.

Indrio F, Riezzo G, Raimondi F, Bisceglia M, Filannino A, Cavallo L, Francavilla R (2011) Lactobacillus reuteri accelerates gastric emptying and improves regurgitation in infants. Eur J Clin Investig 41(4):417–422CrossRef

15.

Jones SE, Versalovic J (2009) Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors. BMC Microbiol 11(9):35CrossRef

16.

Lin YP, Thibodeaux CH, Peña JA, Ferry GD, Versalovic J (2008) Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun. Inflamm Bowel Dis 14(8):1068–1083PubMedCrossRef

17.

Liu Y, Fatheree NY, Mangalat N, Rhoads JM (2010) Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation. Am J Physiol Gastrointest Liver Physiol 299(5):G1087–G1096PubMedCrossRefPubMedCentral

18.

Liu Y, Fatheree NY, Mangalat N, Rhoads JM (2012) Lactobacillus reuteri strains reduce incidence and severity of experimental necrotizing enterocolitis via modulation of TLR4 and NF-κB signaling in the intestine. Am J Physiol Gastrointest Liver Physiol 302(6):G608–G617PubMedCrossRefPubMedCentral

19.

Oncel MY, Sari FN, Arayici S, Guzoglu N, Erdeve O, Uras N, Oguz SS, Dilmen U (2014) Lactobacillus reuteri for the prevention of necrotising enterocolitis in very low birthweight infants: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 99(2):F110–F115PubMedCrossRef

20.

Reuter G (2001) The Lactobacillus and Bifidobacterium microflora of the human intestine: composition and succession. Curr Issues Intest Microbiol 2:43–53PubMed

21.

Rojas MA, Lozano JM, Rojas MX, Rodriguez VA, Rondon MA, Bastidas JA, Perez LA, Rojas C, Ovalle O, Garcia-Harker JE, Tamayo ME, Ruiz GC, Ballesteros A, Archila MM, Arevalo M (2012) Prophylactic probiotics to prevent death and nosocomial infection in preterm infants. Pediatrics 130(5):e1113–e1120PubMedCrossRef

22.

Romano C, Ferrau V, Cavataio F, Iacono G, Spina M, Lionetti E, Comisi F, Famiani A, Comito D (2010) Lactobacillus reuteri in children with functional abdominal pain (FAP). J Paediatr Child Health 824

23.

Rosander A, Connolly E, Roos S (2008) Removal of antibiotic resistance gene-carrying plasmids from Lactobacillus reuteri ATCC 55730 and characterization of the resulting daughter strain, L. reuteri DSM 17938. Appl Environ Microbiol 74(19):6032–6040PubMedCrossRefPubMedCentral

24.

Savino F, Cordisco L, Tarasco V, Palumeri E, Calabrese R, Oggero R, Roos S, Matteuzzi D (2010) Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial. Pediatrics 126(3):e526–e533PubMedCrossRef

25.

Sung V, Hiscock H, Tang ML, Mensah FK, Nation ML, Satzke C, Heine RG, Stock A, Barr RG, Wake M (2014) Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial. BMJ 1(348):g2107CrossRef

26.

Szajewska H, Gyrczuk E, Horvath A (2013) Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial. J Pediatr 162:257–262PubMedCrossRef

27.

Szajewska H, Guarino A, Hojsak I, Indrio F, Kolacek S, Shamir R, Vandenplas Y, Weizman Z (2014) Use of Probiotics for Management of Acute Gastroenteritis: A Position Paper by the ESPGHAN Working Group for Probiotics and Prebiotics. J Pediatr Gastroenterol Nutr 58(4):531–539

28.

Szajewska H, Urbańska M, Chmielewska A, Weizman Z, Shamir R (2014) Meta-analysis: Lactobacillus reuteri strain DSM 17938 (and the original strain ATCC 55730) for treating acute gastroenteritis in children. Benefic Microbes 24:1–9

29.

Talarico TL, Casas IA, Chung TC, Dobrogosz WJ (1988) Production and isolation of reuterin, a growth inhibitor produced by Lactobacillus reuteri. Antimicrob Agents Chemother 32(12):1854–1858PubMedCrossRefPubMedCentral

30.

Valeur N, Engel P, Carbajal N, Connolly E, Ladefoged K (2004) Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Appl Environ Microbiol 70(2):1176–1181PubMedCrossRefPubMedCentral

31.

Wanke M, Szajewska H (2012) Lack of an effect of Lactobacillus reuteri DSM 17938 in preventing nosocomial diarrhea in children: a randomized, double-blind, placebo-controlled trial. J Pediatr 161(1):40–43.e1PubMedCrossRef

Title: The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: a review of the current evidence
Authors: Magdalena Urbańska
Hania Szajewska
Publication date: 01-10-2014
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Pediatrics / Issue 10/2014
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI: https://doi.org/10.1007/s00431-014-2328-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: a review of the current evidence

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 10/2014

Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT): case report of reversible coma and status epilepticus in an adolescent patient and review of the literature

The role of IL-6 572 C/G, 190 C/T, and 174 G/C gene polymorphisms in children’s obesity

The effect of inhaled nitric oxide therapy on thromboelastogram in newborns with persistent pulmonary hypertension

How common are long-lasting, intensely itching vaccination granulomas and contact allergy to aluminium induced by currently used pediatric vaccines? A prospective cohort study

Aarskog-Scott syndrome: a novel mutation in the FGD1 gene associated with severe craniofacial dysplasia

Odontoid infiltration and spinal compression in Farber Disease: reversal by haematopoietic stem cell transplantation